Pharmaceutical Technology's In the Lab eNewsletter 09-02-2020

Dissolution testing is an important aspect of drug development as it provides stability parameters and helps predict drug behavior in-vivo.

How real estate can accelerate productivity as life sciences companies prioritize COVID-19 therapeutics, vaccines, and new diagnostics R&D amidst new guidelines.

The Pentafill L + Fill is a new bench-top vial filling and sealing machine for lab research and small quantity start-up production.

The register supports cross-functional teams of chemists and biologists in developing non-natural, chemically-modified therapeutics for drug discovery.

AbCellera’s recent acquisition of the OrthoMab bispecific platform is expected to accelerate antibody product development.

In the study, GigaGen presents a novel technology for producing a new class of drug, recombinant hyperimmunes, that may potentially generate new COVID-19 therapies.

Thermo Fisher Scientific is increasing access to cry-electron microscopy with the help of contract research organizations.

Move It Adjustable Spacing Pipettes are a simple and safe solution for synchronous pipetting of a series of samples between different vessel formats.

With the ability to be uniquely programmed, the devices provide user interfaces that can integrate with other systems and IoT devices, giving labs the ability to create their own Lab of the Future initiatives.

The expansion will involve using the facilities’ existing central utilities and labs to supplement its small-scale and large-scale assets.

PPD announced it will provide drug development services to advance Pfizer’s portfolio.